Search hospitals > Hawaii > Honolulu

Cancer Research Center of Hawaii

Claim this profile
Honolulu, Hawaii 96813
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
421 reported clinical trials
16 medical researchers
Photo of Cancer Research Center of Hawaii in HonoluluPhoto of Cancer Research Center of Hawaii in Honolulu

Summary

Cancer Research Center of Hawaii is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Cancer Research Center of Hawaii is involved with conducting 421 clinical trials across 417 conditions. There are 16 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.

Area of expertise

1Cancer
Global Leader
Cancer Research Center of Hawaii has run 103 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Cancer Research Center of Hawaii has run 82 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Cancer Research Center of Hawaii

Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Squamous Cell Carcinoma
Tumors
Colorectal Cancer
Ovarian Cancer
Bladder Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cancer Research Center of Hawaii?
Cancer Research Center of Hawaii is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Cancer Research Center of Hawaii is involved with conducting 421 clinical trials across 417 conditions. There are 16 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.
Where is Cancer Research Center of Hawaii located?
The Cancer Research Center of Hawaii is situated at the University of Hawaii Cancer Center in Honolulu, HI, on the University of Hawaii at Manoa campus. It is located near the intersection of East-West Road and University Avenue.
Who should I call to ask about financial aid or insurance network?
For cancer patients in Hawaii seeking financial assistance and insurance support, the following resources are available: - **Hawaii Society of Clinical Oncology (HSCO) and Association of Community Cancer Centers (ACCC):** Offers a digital Patient Assistance & Reimbursement Guide with information on financial assistance programs, including direct links, phone numbers, and eligibility criteria. - **American Cancer Society in Hawaii:** Provides free programs, services, and emotional support for managing cancer treatment and recovery. Contact at 1-800-227-2345 for patient services and information. - **The Queen's Health System:** Offers financial resources, health insurance coverage options, and a Billing Portal on MyChart for secure online payments. - **Hawaii Children's Cancer Foundation:** Provides financial assistance for families with a child diagnosed with cancer. Contact at 808-528-5161 for more information and eligibility requirements. - **Hawaii Cancer Care:** Offers financial assistance for cancer patients, with details available on their website.
What insurance does Cancer Research Center of Hawaii accept?
The Cancer Center of Hawaii, part of The Queen's Medical Center, accepts various insurance plans for cancer care services. For detailed information on accepted insurance plans, contact the Cancer Center of Hawaii directly. City of Hope hospitals and Outpatient Care Centers in Hawaii accept commercial insurance, Medicare, Medicaid, and some U.S. Department of Veterans Affairs and TRICARE plans.
What awards or recognition has Cancer Research Center of Hawaii received?
The Cancer Research Center of Hawaii, located in Honolulu, has been awarded a $6 million Cancer Center Support Grant for its research efforts. It holds a national designation that aids in securing approximately $40 million yearly in grants from the National Institutes of Health. The center's Multiethnic Cohort (MEC) study, funded by the National Cancer Institute since 1993, plays a crucial role in exploring cancer disparities across various ethnic groups.